These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 19255825

  • 1. Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy.
    Gupta A, Khaira A, Singh B, Bhowmik DM, Tiwari SC.
    Clin Exp Nephrol; 2009 Aug; 13(4):402-403. PubMed ID: 19255825
    [No Abstract] [Full Text] [Related]

  • 2. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
    López V, Martin M, Cobelo C, Aranda P, Cabello M, Sola E, Gutierrez C, Burgos D, Martínez D, Hernandez D.
    Transplant Proc; 2010 Oct; 42(8):2883-5. PubMed ID: 20970559
    [Abstract] [Full Text] [Related]

  • 3. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V, Buksa M, Loza V, Kulic M.
    Med Arh; 2009 Oct; 63(6):343-9. PubMed ID: 20380117
    [Abstract] [Full Text] [Related]

  • 4. Aliskiren combined with losartan in diabetes and nephropathy.
    Lindner T.
    N Engl J Med; 2008 Sep 04; 359(10):1068-9; author reply 1069-70. PubMed ID: 18777612
    [No Abstract] [Full Text] [Related]

  • 5. Aliskiren combined with losartan in diabetes and nephropathy.
    Anderson S, Komers R.
    N Engl J Med; 2008 Sep 04; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
    [No Abstract] [Full Text] [Related]

  • 6. [Renin inhibition and the kidney].
    Ecder T.
    Turk Kardiyol Dern Ars; 2009 Oct 04; 37 Suppl 7():28-31. PubMed ID: 20019474
    [Abstract] [Full Text] [Related]

  • 7. Aliskiren and dual therapy in type 2 diabetes mellitus.
    Ingelfinger JR.
    N Engl J Med; 2008 Jun 05; 358(23):2503-5. PubMed ID: 18525047
    [No Abstract] [Full Text] [Related]

  • 8. Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?
    Hollenberg NK, Fisher ND, Nussberger J, Moukarbel GV, Barkoudah E, Danser AH.
    J Hypertens; 2011 Dec 05; 29(12):2454-61. PubMed ID: 22002336
    [Abstract] [Full Text] [Related]

  • 9. Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study.
    De Nicola L, Zamboli P, Bellizzi V, Stanzione G, Russo D, Nappi F, Minco M, Chiodini P, Conte G, Minutolo R.
    Am J Kidney Dis; 2011 Jun 05; 57(6):961-3. PubMed ID: 21507536
    [No Abstract] [Full Text] [Related]

  • 10. Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
    Freiberger V, Amann K, Heemann U, Frank H.
    Transpl Int; 2009 Nov 05; 22(11):1110-3. PubMed ID: 19497068
    [Abstract] [Full Text] [Related]

  • 11. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
    Chrysant SG, Murray AV, Hoppe UC, Dattani D, Patel S, Hsu H, Zhang J.
    Curr Med Res Opin; 2008 Apr 05; 24(4):1039-47. PubMed ID: 18307835
    [Abstract] [Full Text] [Related]

  • 12. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
    Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.
    Am J Kidney Dis; 2008 Sep 05; 52(3):475-85. PubMed ID: 18468748
    [Abstract] [Full Text] [Related]

  • 13. Aliskiren combined with losartan in diabetes and nephropathy.
    Panesar M, Damodar A.
    N Engl J Med; 2008 Sep 04; 359(10):1068; author reply 1069-70. PubMed ID: 18768954
    [No Abstract] [Full Text] [Related]

  • 14. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
    Doulton TW, MacGregor GA.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec 04; 10(4):185-9. PubMed ID: 19617273
    [Abstract] [Full Text] [Related]

  • 15. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
    Schleich F, Krzesinski JM, Piérard L, Scheen AJ.
    Rev Med Liege; 2008 Apr 04; 63(4):174-81. PubMed ID: 18575070
    [Abstract] [Full Text] [Related]

  • 16. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E, Barton J, Nussberger J, Mulcahy D, Jensen C, Dicker P, Stanton A.
    Hypertension; 2007 Feb 04; 49(2):276-84. PubMed ID: 17159081
    [Abstract] [Full Text] [Related]

  • 17. Effect of direct renin inhibitor, aliskiren, on peripheral blood monocyte subsets and myocardial salvage in patients with primary acute myocardial infarction.
    Ozaki Y, Imanishi T, Tanimoto T, Kashiwagi M, Tsujioka H, Sougawa H, Orii M, Shiono Y, Shimamura K, Ishibashi K, Komukai K, Ino Y, Kitabata H, Akasaka T.
    Circ J; 2012 Feb 04; 76(6):1461-8. PubMed ID: 22453004
    [Abstract] [Full Text] [Related]

  • 18. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
    Tempelhof MW.
    South Med J; 2009 Dec 04; 102(12):1201-2. PubMed ID: 20016423
    [No Abstract] [Full Text] [Related]

  • 19. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M, Simioni N, Masiero A.
    Minerva Endocrinol; 2009 Dec 04; 34(4):333-8. PubMed ID: 20046162
    [Abstract] [Full Text] [Related]

  • 20. Does direct inhibition bring direct benefit?
    Abe S, Taguchi I, Inoue T.
    Circ J; 2012 Dec 04; 76(6):1326. PubMed ID: 22739081
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.